| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aytu Biopharma, Inc (AYTU) has 9 insiders with recent SEC Form 4 filings, including 13 buys and 1 sell. AYTU is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.82M | $12.04M | - | |
| CEO | 184.7K | $461.8K | - | |
| Other | 61.6K | $153.9K | - | |
| Other | 36.1K | $90.3K | - | |
| CFO | 32.2K | $80.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 20, 2019 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 78,788 | $0.86 | $67,749.80 | +0.2% | |
| Dec 19, 2019 | Disbrow Joshua R.56 | Chief Executive Officer | Buy | 55,000 | $0.89 | $48,824.00 | +5.6% | |
| Dec 21, 2018 | Green David A | Chief Financial Officer | Sell | 3,330 | $0.81 | $2,710.95 | -1.2% | |
| Mar 6, 2018 | Disbrow Joshua R.56 | Chief Executive Officer | Buy | 226,105 | $0.45 | $101,747.25 | +85.4% | |
| Mar 6, 2018 | Green David A | Chief Financial Officer | Buy | 66,600 | $0.45 | $29,970.00 | +88.8% | |
| Mar 6, 2018 | Disbrow Jarrett | Chief Operating Officer | Buy | 226,105 | $0.45 | $101,747.25 | +106.0% | |
| Nov 2, 2016 | Cantrell Gary | Director | Buy | 33,333 | $1.50 | $49,999.50 | +51.3% | |
| Nov 2, 2016 | Gould Gregory A | Chief Financial Officer | Buy | 66,666 | $1.50 | $99,999.00 | +32.2% | |
| Nov 2, 2016 | Disbrow Jarrett | Chief Operating Officer | Buy | 166,666 | $1.50 | $249,999.00 | +67.5% | |
| Nov 2, 2016 | Disbrow Joshua R.56 | Chief Executive Officer | Buy | 166,666 | $1.50 | $249,999.00 | +60.4% |